Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,307.20 -80.41 -0.52%
S&P 500 1,655.35 -13.81 -0.83%
Nasdaq 3,463.30 -38.82 -1.11%
Ticker Volume Price Price Delta
STOXX 50 2,762.68 -72.33 -2.55%
FTSE 100 6,708.57 -131.70 -1.93%
DAX 8,308.05 -222.84 -2.61%
Ticker Volume Price Price Delta
Nikkei 14,484.00 -1,143.28 -7.32%
Hang Seng 22,669.70 -591.40 -2.54%
S&P/ASX 200 5,062.45 -102.92 -1.99%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Pain Therapeutics Inc

+ Add to Watchlist

PTIE:US

2.8800 USD 0.2000 6.49%

As of 20:10:00 ET on 05/22/2013.

Company Profile for Pain Therapeutics Inc (PTIE)

Pain Therapeutics, Inc. develops drugs using it proprietary technology. The Company develops safer or more efficacious drugs for use in pain management, particularly in the area of opioid painkillers. Pain Therapeutics has products in clinical trials.

Contact Information

Pain Therapeutics Inc

7801 N Capital of Texas Highwa
Suite 260
Austin, TX 78731
United States
Phone: 1-650-624-8200
Fax: 1-650-624-8222

Key Executives for Pain Therapeutics Inc (PTIE)

Remi BarbierChairman/President/CEONadav FriedmannCOO/Chief Medical Officer
Grant L SchoenhardChief Scientific OfficerPeter S RoddyVP/CFO
Michael J O'DonnellSecretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil